Clinical Trial Update: Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction [NA]

View source ↗

Summary

Completed clinical trial evaluating a Humanity Neurotech device for cognitive dysfunction in adults with post-acute COVID-19 syndrome (long COVID).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Humanity Neurotech Device

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Post-Acute COVID-19 Syndrome, Cognitive Dysfunction | NA | Status: COMPLETED